Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models

Sebastian, Aimy; Loots, Gabriela G.

doi:10.1016/j.metabol.2017.10.005

Title: Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models

Journal Article · 28 February 2018 · Metabolism, Clinical and Experimental

DOI: https://doi.org/10.1016/j.metabol.2017.10.005 · OSTI ID:1437749

Sebastian, Aimy; Loots, Gabriela G.

Not Available

View Journal Article

Cite

Export

Save

Sponsoring Organization:: USDOE

Grant/Contract Number:: AC52-07NA27344

OSTI ID:: 1437749

Journal Information:: Metabolism, Clinical and Experimental, Journal Name: Metabolism, Clinical and Experimental Journal Issue: C Vol. 80; ISSN 0026-0495

Publisher:: ElsevierCopyright Statement

Country of Publication:: United States

Language:: English

References (69)

A 52-kb deletion in theSOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population Staehling-Hampton, Karen; Proll, Sean; Paeper, Bryan W. American Journal of Medical Genetics, Vol. 110, Issue 2 https://doi.org/10.1002/ajmg.10401	journal	May 2002
A novel homozygous missense mutation (c.610G>A, p.Gly204Ser) in the WNT7A gene causes tetra-amelia in two Saudi families Eyaid, Wafaa; Al-Qattan, Mohammad M.; Al Abdulkareem, Ibrahim American Journal of Medical Genetics Part A, Vol. 155, Issue 3 https://doi.org/10.1002/ajmg.a.33717	journal	February 2011
First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function Piters, Elke; Culha, Cavit; Moester, Martiene Human Mutation, Vol. 31, Issue 7 https://doi.org/10.1002/humu.21274	journal	May 2010
Absence of sclerostin adversely affects B-cell survival Cain, Corey J.; Rueda, Randell; McLelland, Bryce Journal of Bone and Mineral Research, Vol. 27, Issue 7 https://doi.org/10.1002/jbmr.1608	journal	June 2012
Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody Padhi, Desmond; Jang, Graham; Stouch, Brian Journal of Bone and Mineral Research, Vol. 26, Issue 1 https://doi.org/10.1002/jbmr.173	journal	June 2010
Van Buchem disease: Clinical, biochemical, and densitometric features of patients and disease carriers van Lierop, Antoon H.; Hamdy, Neveen AT; van Egmond, Martje E. Journal of Bone and Mineral Research, Vol. 28, Issue 4 https://doi.org/10.1002/jbmr.1794	journal	March 2013
Sclerostin Deficiency Is Linked to Altered Bone Composition: SCLEROSTIN DEFICIENCY IS LINKED TO ALTERED BONE COMPOSITION Hassler, Norbert; Roschger, Andreas; Gamsjaeger, Sonja Journal of Bone and Mineral Research, Vol. 29, Issue 10 https://doi.org/10.1002/jbmr.2259	journal	September 2014
HDAC5 Controls MEF2C-Driven Sclerostin Expression in Osteocytes: HDAC5 REGULATES SCLEROSTIN LEVELS IN OSTEOCYTES Wein, Marc N.; Spatz, Jordan; Nishimori, Shigeki Journal of Bone and Mineral Research, Vol. 30, Issue 3 https://doi.org/10.1002/jbmr.2381	journal	February 2015
A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone: LRP4 AS A BONE ANCHOR OF SCLEROSTIN Fijalkowski, Igor; Geets, Ellen; Steenackers, Ellen Journal of Bone and Mineral Research, Vol. 31, Issue 4 https://doi.org/10.1002/jbmr.2782	journal	January 2016
The Lrp4 R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans Boudin, Eveline; Yorgan, Timur; Fijalkowski, Igor Journal of Bone and Mineral Research, Vol. 32, Issue 8 https://doi.org/10.1002/jbmr.3160	journal	August 2017
Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover van Lierop, Antoon H.; Hamdy, Neveen AT; Hamersma, Herman Journal of Bone and Mineral Research, Vol. 26, Issue 12 https://doi.org/10.1002/jbmr.474	journal	November 2011
Osteocyte: the unrecognized side of bone tissue Rochefort, G. Y.; Pallu, S.; Benhamou, C. L. Osteoporosis International, Vol. 21, Issue 9 https://doi.org/10.1007/s00198-010-1194-5	journal	March 2010
Sclerostin: Current Knowledge and Future Perspectives Moester, M. J. C.; Papapoulos, S. E.; Löwik, C. W. G. M. Calcified Tissue International, Vol. 87, Issue 2 https://doi.org/10.1007/s00223-010-9372-1	journal	May 2010
Sclerosteosis (craniotubular hyperostosis-syndactyly) with complex hyperphalangy of the index finger Yagi, Hiroko; Takagi, Masaki; Hasegawa, Yukihiro Pediatric Radiology, Vol. 45, Issue 8 https://doi.org/10.1007/s00247-015-3292-1	journal	April 2015
Sclerostin and skeletal health Sharifi, Maryam; Ereifej, Lisa; Lewiecki, E. Michael Reviews in Endocrine and Metabolic Disorders, Vol. 16, Issue 2 https://doi.org/10.1007/s11154-015-9311-6	journal	February 2015
From disease to treatment: from rare skeletal disorders to treatments for osteoporosis Appelman-Dijkstra, Natasha M.; Papapoulos, Socrates E. Endocrine, Vol. 52, Issue 3 https://doi.org/10.1007/s12020-016-0888-7	journal	February 2016
A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the gene Balemans, W.; Cleiren, E.; Siebers, U. Bone, Vol. 36, Issue 6 https://doi.org/10.1016/j.bone.2005.02.019	journal	June 2005
SOST is a target gene for PTH in bone Keller, Hansjoerg; Kneissel, Michaela Bone, Vol. 37, Issue 2 https://doi.org/10.1016/j.bone.2005.03.018	journal	August 2005
Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading Tu, Xiaolin; Rhee, Yumie; Condon, Keith W. Bone, Vol. 50, Issue 1 https://doi.org/10.1016/j.bone.2011.10.025	journal	January 2012
Novel SOST gene mutation in a sclerosteosis patient and her parents Bhadada, Sanjay Kumar; Rastogi, Ashu; Steenackers, Ellen Bone, Vol. 52, Issue 2 https://doi.org/10.1016/j.bone.2012.10.009	journal	February 2013
Role and mechanism of action of sclerostin in bone Delgado-Calle, Jesus; Sato, Amy Y.; Bellido, Teresita Bone, Vol. 96 https://doi.org/10.1016/j.bone.2016.10.007	journal	March 2017
Transcriptional control of Sost in bone Sebastian, Aimy; Loots, Gabriela G. Bone, Vol. 96 https://doi.org/10.1016/j.bone.2016.10.009	journal	March 2017
Sclerostin deficiency in humans van Lierop, Antoon H.; Appelman-Dijkstra, Natasha M.; Papapoulos, Socrates E. Bone, Vol. 96 https://doi.org/10.1016/j.bone.2016.10.010	journal	March 2017
Regulatory signal transduction pathways for class IIa histone deacetylases Parra, Maribel; Verdin, Eric Current Opinion in Pharmacology, Vol. 10, Issue 4 https://doi.org/10.1016/j.coph.2010.04.004	journal	August 2010
Novel SOST gene mutation in a sclerosteosis patient from Morocco: A case report Belkhribchia, Mohamed Reda; Collet, Corinne; Laplanche, Jean-Louis European Journal of Medical Genetics, Vol. 57, Issue 4 https://doi.org/10.1016/j.ejmg.2014.02.007	journal	March 2014
The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouse Glasson, S. S.; Chambers, M. G.; Van Den Berg, W. B. Osteoarthritis and Cartilage, Vol. 18 https://doi.org/10.1016/j.joca.2010.05.025	journal	October 2010
Genetic evidence that SOST inhibits WNT signaling in the limb Collette, Nicole M.; Genetos, Damian C.; Murugesh, Deepa Developmental Biology, Vol. 342, Issue 2 https://doi.org/10.1016/j.ydbio.2010.03.021	journal	June 2010
Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner Collette, Nicole M.; Yee, Cristal S.; Murugesh, Deepa Developmental Biology, Vol. 383, Issue 1 https://doi.org/10.1016/j.ydbio.2013.08.015	journal	November 2013
An auditory profile of sclerosteosis Potgieter, J. M.; Swanepoel, D. W.; Heinze, B. M. The Journal of Laryngology & Otology, Vol. 128, Issue 4 https://doi.org/10.1017/S0022215113002648	journal	March 2014
The natural history of sclerosteosis: The natural history of sclerosteosis Hamersma, H.; Gardner, J.; Beighton, P. Clinical Genetics, Vol. 63, Issue 3 https://doi.org/10.1034/j.1399-0004.2003.00036.x	journal	March 2003
Dorsalizing signal Wnt-7a required for normal polarity of D–V and A–P axes of mouse limb Parr, Brian A.; McMahon, Andrew P. Nature, Vol. 374, Issue 6520 https://doi.org/10.1038/374350a0	journal	March 1995
LRP5 and bone mass regulation: Where are we now? Johnson, Mark L. BoneKEy Reports, Vol. 1 https://doi.org/10.1038/bonekey.2012.1	journal	January 2012
SIKs control osteocyte responses to parathyroid hormone Wein, Marc N.; Liang, Yanke; Goransson, Olga Nature Communications, Vol. 7, Issue 1 https://doi.org/10.1038/ncomms13176	journal	October 2016
Parathyroid hormone analogues in the treatment of osteoporosis Kraenzlin, Marius E.; Meier, Christian Nature Reviews Endocrinology, Vol. 7, Issue 11 https://doi.org/10.1038/nrendo.2011.108	journal	July 2011
The complex world of WNT receptor signalling Niehrs, Christof Nature Reviews Molecular Cell Biology, Vol. 13, Issue 12 https://doi.org/10.1038/nrm3470	journal	November 2012
Romosozumab in Postmenopausal Women with Low Bone Mineral Density McClung, Michael R.; Grauer, Andreas; Boonen, Steven New England Journal of Medicine, Vol. 370, Issue 5 https://doi.org/10.1056/NEJMoa1305224	journal	January 2014
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis Saag, Kenneth G.; Petersen, Jeffrey; Brandi, Maria Luisa New England Journal of Medicine, Vol. 377, Issue 15 https://doi.org/10.1056/NEJMoa1708322	journal	October 2017
Targeted deletion of Sost distal enhancer increases bone formation and bone mass Collette, N. M.; Genetos, D. C.; Economides, A. N. Proceedings of the National Academy of Sciences, Vol. 109, Issue 35 https://doi.org/10.1073/pnas.1207188109	journal	August 2012
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels Chang, Ming-Kang; Kramer, Ina; Huber, Thomas Proceedings of the National Academy of Sciences, Vol. 111, Issue 48 https://doi.org/10.1073/pnas.1413828111	journal	November 2014
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function Leupin, Olivier; Piters, Elke; Halleux, Christine Journal of Biological Chemistry, Vol. 286, Issue 22 https://doi.org/10.1074/jbc.M110.190330	journal	April 2011
Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin Robling, Alexander G.; Niziolek, Paul J.; Baldridge, Lee A. Journal of Biological Chemistry, Vol. 283, Issue 9 https://doi.org/10.1074/jbc.M705092200	journal	December 2007
Van Buchem Disease (Hyperostosis Corticalis Generalisata) Maps to Chromosome 17q12-q21 Van Hul, Wim; Balemans, Wendy; Van Hul, Els The American Journal of Human Genetics, Vol. 62, Issue 2 https://doi.org/10.1086/301721	journal	February 1998
Localization of the Gene for Sclerosteosis to the van Buchem Disease–Gene Region on Chromosome 17q12–q21 Balemans, Wendy; Van Den Ende, Jenneke; Freire Paes-Alves, Auristela The American Journal of Human Genetics, Vol. 64, Issue 6 https://doi.org/10.1086/302416	journal	June 1999
Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Protein Brunkow, Mary E.; Gardner, Jessica C.; Van Ness, Jeff The American Journal of Human Genetics, Vol. 68, Issue 3 https://doi.org/10.1086/318811	journal	March 2001
Homozygous WNT3 Mutation Causes Tetra-Amelia in a Large Consanguineous Family Niemann, Stephan; Zhao, Chengfeng; Pascu, Filon The American Journal of Human Genetics, Vol. 74, Issue 3 https://doi.org/10.1086/382196	journal	March 2004
A Known SOST Gene Mutation Causes Sclerosteosis in a Familial and an Isolated Case from Brazilian Origin Kim, Chong Ae; Honjo, Rachel; Bertola, Débora Genetic Testing, Vol. 12, Issue 4 https://doi.org/10.1089/gte.2008.0036	journal	December 2008
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist Winkler, D. G. The EMBO Journal, Vol. 22, Issue 23 https://doi.org/10.1093/emboj/cdg599	journal	December 2003
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) Balemans, W. Human Molecular Genetics, Vol. 10, Issue 5 https://doi.org/10.1093/hmg/10.5.537	journal	March 2001
Molecular genetics of too much bone Janssens, K. Human Molecular Genetics, Vol. 11, Issue 20 https://doi.org/10.1093/hmg/11.20.2385	journal	October 2002
Wnt signaling in cardiovascular disease: opportunities and challenges Gay, Austin; Towler, Dwight A. Current Opinion in Lipidology, Vol. 28, Issue 5 https://doi.org/10.1097/MOL.0000000000000445	journal	January 2017
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease Loots, G. G. Genome Research, Vol. 15, Issue 7 https://doi.org/10.1101/gr.3437105	journal	June 2005
Sclerosteosis caused by a novel nonsense mutation of SOST in a consanguineous family He, Wen‐Tao; Chen, Chen; Pan, Chu Clinical Genetics, Vol. 89, Issue 2 https://doi.org/10.1111/cge.12655	journal	September 2015
The syndromic status of sclerosteosis and van Buchem disease Beighton, P.; Barnard, A.; Hamersma, H. Clinical Genetics, Vol. 25, Issue 2 https://doi.org/10.1111/j.1399-0004.1984.tb00481.x	journal	February 1984
Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction Wehmeyer, Corinna; Frank, Svetlana; Beckmann, Denise Science Translational Medicine, Vol. 8, Issue 330 https://doi.org/10.1126/scitranslmed.aac4351	journal	March 2016
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease Balemans, W. Journal of Medical Genetics, Vol. 39, Issue 2 https://doi.org/10.1136/jmg.39.2.91	journal	February 2002
A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis Fayez, Alaaeldin; Aglan, Mona; Esmaiel, Nora BioMed Research International, Vol. 2015 https://doi.org/10.1155/2015/517815	journal	January 2015
Building bone to reverse osteoporosis and repair fractures Khosla, Sundeep; Westendorf, Jennifer J.; Oursler, Merry Jo Journal of Clinical Investigation, Vol. 118, Issue 2 https://doi.org/10.1172/JCI33612	journal	February 2008
Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways Bouaziz, Wafa; Funck-Brentano, Thomas; Lin, Hilène Arthritis Research & Therapy, Vol. 17, Issue 1 https://doi.org/10.1186/s13075-015-0540-6	journal	January 2015
Bone Remodeling Hadjidakis, D. J.; Androulakis, I. I. Annals of the New York Academy of Sciences, Vol. 1092, Issue 1 https://doi.org/10.1196/annals.1365.035	journal	December 2006
Osteocytes as Dynamic Multifunctional Cells Bonewald, L. F. Annals of the New York Academy of Sciences, Vol. 1116, Issue 1 https://doi.org/10.1196/annals.1402.018	journal	November 2007
Bone Mineral Density in Sclerosteosis; Affected Individuals and Gene Carriers Gardner, Jessica C.; van Bezooijen, Rutger L.; Mervis, Benjamin The Journal of Clinical Endocrinology & Metabolism, Vol. 90, Issue 12 https://doi.org/10.1210/jc.2005-1235	journal	December 2005
Control of the SOST Bone Enhancer by PTH Using MEF2 Transcription Factors Leupin, Olivier; Kramer, Ina; Collette, Nicole M. Journal of Bone and Mineral Research, Vol. 22, Issue 12 https://doi.org/10.1359/jbmr.070804	journal	August 2007
Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength Li, Xiaodong; Ominsky, Michael S.; Niu, Qing-Tian Journal of Bone and Mineral Research, Vol. 23, Issue 6 https://doi.org/10.1359/jbmr.080216	journal	February 2008
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis* Li, Xiaodong; Ominsky, Michael S.; Warmington, Kelly S. Journal of Bone and Mineral Research, Vol. 24, Issue 4 https://doi.org/10.1359/jbmr.081206	journal	April 2009
Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β-Catenin Signaling Lin, Chuwen; Jiang, Xuan; Dai, Zhongquan Journal of Bone and Mineral Research, Vol. 24, Issue 10 https://doi.org/10.1359/jbmr.090411	journal	October 2009
Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient mice Kramer, Ina; Loots, Gabriela G.; Studer, Anne Journal of Bone and Mineral Research, Vol. 25, Issue 2 https://doi.org/10.1359/jbmr.090730	journal	December 2009
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes O'Brien, Charles A.; Plotkin, Lilian I.; Galli, Carlo PLoS ONE, Vol. 3, Issue 8 https://doi.org/10.1371/journal.pone.0002942	journal	August 2008
Normal Bone Anatomy and Physiology Clarke, Bart Clinical Journal of the American Society of Nephrology, Vol. 3, Issue Supplement 3 https://doi.org/10.2215/CJN.04151206	journal	November 2008
An uncommon familial systemic disease of the skeleton: Hyperostosis corticalis generalisata familiaris van Buchem, F. S. P.; Hadders, H. N.; Ubbens, R. Acta Radiologica, Vol. 44, Issue 2 https://doi.org/10.3109/00016925509170789	journal	August 1955

Similar Records

Genetic evidence that SOST inhibits WNT signaling in the limb

Journal Article · 2010 · Developmental Biology · OSTI ID:1839869

Collette, Nicole M.; Genetos, Damian C.; Murugesh, Deepa; +2 more

Animal model of human disease

Journal Article · 1978 · Am. J. Pathol.; (United States) · OSTI ID:6451842

Setlow, R B; Woodhead, A D; Hart, R W

Animal models of beryllium-induced lung disease

Journal Article · 1996 · Environmental Health Perspectives · OSTI ID:530620

Finch, G L; Hoover, M D; Hahn, F F

Title: Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models

Citation Formats

References (69)

Similar Records

Related Subjects